Next Generation RNA Medicines: STARR® Self-Amplifying mRNA Vaccines

• Differences between Arcturus sa-mRNA and approved mRNA vaccines
• EMA Approval Case Studies:
  • Characterization of mRNA
  • Fragments in Drug Substance
  • Efficacy/tolerability of mRNA Fragments In Vivo
  • Lipid Mass Balance
  • Future Perspectives

Speakers:

Yurong Guo

Senior Director - Analytical Development & Quality Control

Arcturus Therapeutics